MedTrace Logo

Escitalopram and Depression in Elderly Alzheimer's Patients

NCT00488670 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2011-06-06

No results posted yet for this study

Summary

To investigate the effect of Escitalopram in a large and diverse of dementia patients suffering from depression.

Conditions

  • Depressive Disorder

Interventions

DRUG

Escitalopram

See Detailed Description.

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Kiran Rabheru, MD · University of British Columbia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00488670 on ClinicalTrials.gov